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Introduction
Foslip and Fospeg are new formulations of the photosen-
sitzer m-THPC, intended for use in Photodynamic Ther-
apy (PDT) of malignancies. Foslip is m-THPC bound to
conventional liposomes, Fospeg consists of m-THPC
bound to pegylated liposomes. Possible differences in
tumour-fluorescence and vasculature kinetics between
Foslip, Fospeg and Foscan were studied using the rat win-
dow-chamber model.
Materials and methods
In 18 rats a dorsal skinfold window-chamber was
installed and a mammary carcinoma was transplanted in
the subcutaneous tissue. The dosage used for intravenous
injection was 0.15 mg of m-THPC for each formulation.
At 7 time-points after injection (5 minutes – 96 hours),
mTHPC-fluoresence at its absorption-peak and auto-fluo-
rescence were detected with a CCD. After correction, m-
THPC fluorescence images were achieved. Fluorescence
intensities of 3 different regions of interest (ROI) were
assessed; tumour-tissue, vasculature and surrounding
connective tissue.
Results
Shortly after injection vascular m-THPC fluorescence was
high for Foscan and Fospeg but not for Foslip. The latter
showed a gradual increase in fluorescence. All photosen-
sitizers showed different fluorescence intensity curves in
time. Fospeg had higher m-THPC fluorescence in tumour
tissue (p < 0.05) between 2 and 8 hours and showed this
trend at later time-points compared to the other photo-
sensitizers. Maximum tumour fluorescence is reached at
48 hours for Foslip and 24 hours for Foscan and Fospeg.
No photosensitizer showed a significant difference
between the tumour and surrounding tissue fluorescence.
Conclusion
There are differences in fluorescence intensities of Fospeg,
Foslip and Foscan at all time-points. Pegylated liposomes
showed higher uptake in tumour. No photosensitizer
showed tumour-selectivity.
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